Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AGC Biologics is partnering with clinical-stage biotech company Molecular Partners to develop a new class of custom-built protein therapeutics known as DARPin.
read more
Avacta has entered into a collaboration with Integumen to evaluate recently generated Affimer reagents that bind the SARS-COV-2 spike protein for the detection of the coronavirus in waste water, to provide a real-time alert system to warn of ...
read more
The FDA has been determining the safest and most appropriate time to resume prioritized domestic inspections of FDA-regulated facilities and other associated activities since we first announced postponement in March.
read more
Cobra Biologics has successfully produced and supplied two further DNA plasmids for the production of CombiGene’s gene therapy drug candidate CG01, which is being developed for the treatment of drug-resistant focal epilepsy.
read more
The CCMI at the NUI Galway and Sexton Biotechnologies announced the approval by an EU Regulatory Authority of a protocol for the manufacture of allogeneic bone marrow MSCs to be given intravenously to high-risk corneal transplant recipients in the ...
read more
Angelini Pharma will be responsible to develop, manufacture and commercialize OV101 for the potential treatment of Angelman syndrome.
read more
Cobra has successfully produced and supplied two further DNA plasmids for the production of CombiGene’s gene therapy drug candidate CG01.
read more
Granules voluntarily recalling 12 lots of Metformin Hydrochloride Extended-Release Tablets due to the detection of NDMA levels above the Acceptable Daily Intake Limit.
read more
Cipla has received final approval for its ANDA for Icatibant Injectable 30mg/3mL from the FDA.
read more
Syneos Health® has signed a new three-year agreement with Pfizer to deliver global product development solutions to support Pfizer's portfolio.
read more
Sanofi and MD Anderson Cancer Center announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune-therapies.
read more
Arch Biopartners engaged a global CRO to initiate and conduct a Phase II trial in the U.S. for its lead drug Metablok for COVID-19 complications.
read more
NeuroRx, in partnership with Relief, announced the independent Data Monitoring Committee has reviewed the findings in the first 30 patients treated in Fast Track trials of Aviptadil in patients with Critical COVID-19 with respiratory failure.
read more
Orgenesis it has entered into a Collaboration Agreement with Educell, a European cell therapy company.
read more
Nabriva has entered into an exclusive agreement with subsidiaries of Merck to market, sell and distribute SIVEXTRO in the United States and certain of its territories.
read more